- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Prescription Dermatological Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Prescription Dermatological Drugsmarket, defines the market attractiveness level of Prescription Dermatological Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Prescription Dermatological Drugs industry, describes the types of Prescription Dermatological Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prescription Dermatological Drugs market and the development prospects and opportunities of Prescription Dermatological Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prescription Dermatological Drugs market in Chapter 13.
By Player:
Merck
PharmaDerm Pharmaceuticals
Mylan Pharmaceuticals
F Hoffmann-La Roche
Johnson & Johnson
Allergan
Allergan Inamed Corporation
Pfizer
Bayer
Allergan Inamed Corporation Inamed Corporation
By Type:
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Prescription Dermatological Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Prescription Dermatological Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Prescription Dermatological Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Prescription Dermatological Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Prescription Dermatological Drugs Market Analysis and Outlook to 2022
-
7.1 Global Prescription Dermatological Drugs Consumption (2017-2022)
-
7.2 United States Prescription Dermatological Drugs Consumption (2017-2022)
-
7.3 Europe Prescription Dermatological Drugs Consumption (2017-2022)
-
7.4 China Prescription Dermatological Drugs Consumption (2017-2022)
-
7.5 Japan Prescription Dermatological Drugs Consumption (2017-2022)
-
7.6 India Prescription Dermatological Drugs Consumption (2017-2022)
-
7.7 South Korea Prescription Dermatological Drugs Consumption (2017-2022)
8 Region and Country-wise Prescription Dermatological Drugs Market Analysis and Outlook to 2028
-
8.1 Global Prescription Dermatological Drugs Consumption Forecast (2022-2028)
-
8.2 United States Prescription Dermatological Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Prescription Dermatological Drugs Consumption Forecast (2022-2028)
-
8.4 China Prescription Dermatological Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Prescription Dermatological Drugs Consumption Forecast (2022-2028)
-
8.6 India Prescription Dermatological Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Prescription Dermatological Drugs Consumption Forecast (2022-2028)
9 Global Prescription Dermatological Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Prescription Dermatological Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-acne Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-aging Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dermatitis Drugs Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hair Loss Drugs Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Skin Cancer Drugs Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Melasma Drugs Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Seborrhea Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Prescription Dermatological Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Prescription Dermatological Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Prescription Dermatological Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-acne Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-aging Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dermatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Hair Loss Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Skin Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Melasma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Seborrhea Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Prescription Dermatological Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Prescription Dermatological Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Prescription Dermatological Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Prescription Dermatological Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Prescription Dermatological Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Prescription Dermatological Drugs Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Prescription Dermatological Drugs Product and Service
-
14.2 PharmaDerm Pharmaceuticals
-
14.2.1 PharmaDerm Pharmaceuticals Company Details
-
14.2.2 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product and Service
-
14.3 Mylan Pharmaceuticals
-
14.3.1 Mylan Pharmaceuticals Company Details
-
14.3.2 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Product and Service
-
14.4 F Hoffmann-La Roche
-
14.4.1 F Hoffmann-La Roche Company Details
-
14.4.2 F Hoffmann-La Roche Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 F Hoffmann-La Roche Prescription Dermatological Drugs Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Prescription Dermatological Drugs Product and Service
-
14.6 Allergan
-
14.6.1 Allergan Company Details
-
14.6.2 Allergan Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Allergan Prescription Dermatological Drugs Product and Service
-
14.7 Allergan Inamed Corporation
-
14.7.1 Allergan Inamed Corporation Company Details
-
14.7.2 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Allergan Inamed Corporation Prescription Dermatological Drugs Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Prescription Dermatological Drugs Product and Service
-
14.9 Bayer
-
14.9.1 Bayer Company Details
-
14.9.2 Bayer Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer Prescription Dermatological Drugs Product and Service
-
14.10 Allergan Inamed Corporation Inamed Corporation
-
14.10.1 Allergan Inamed Corporation Inamed Corporation Company Details
-
14.10.2 Allergan Inamed Corporation Inamed Corporation Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Allergan Inamed Corporation Inamed Corporation Prescription Dermatological Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Prescription Dermatological Drugs
-
Figure Prescription Dermatological Drugs Picture
-
Table Global Prescription Dermatological Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prescription Dermatological Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prescription Dermatological Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Prescription Dermatological Drugs Consumption by Country (2017-2022)
-
Figure United States Prescription Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Prescription Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Prescription Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Prescription Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Prescription Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prescription Dermatological Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription Dermatological Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Prescription Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prescription Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Prescription Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prescription Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prescription Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prescription Dermatological Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-acne Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-aging Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hair Loss Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Skin Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Melasma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Seborrhea Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-acne Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-aging Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hair Loss Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Skin Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melasma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Seborrhea Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Prescription Dermatological Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Prescription Dermatological Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Prescription Dermatological Drugs Product and Service
-
Table PharmaDerm Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product and Service
-
Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Pharmaceuticals Prescription Dermatological Drugs Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Prescription Dermatological Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Prescription Dermatological Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Prescription Dermatological Drugs Product and Service
-
Table Allergan Inamed Corporation (Foundation Year, Company Profile and etc.)
-
Table Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Inamed Corporation Prescription Dermatological Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Prescription Dermatological Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Prescription Dermatological Drugs Product and Service
-
Table Allergan Inamed Corporation Inamed Corporation (Foundation Year, Company Profile and etc.)
-
Table Allergan Inamed Corporation Inamed Corporation Prescription Dermatological Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Inamed Corporation Inamed Corporation Prescription Dermatological Drugs Product and Service
-